iExposure Intervention for Social Anxiety
NCT06409247
Summary
Social anxiety (SA) is a highly prevalent mental health concern, thought to disproportionately affect youth with recent international estimates of more than 30% of individuals reporting clinically elevated symptoms. Despite the prevalence of SA, as few as one in five individuals receive care, due to limited access to evidence-based treatments. Additionally there has been a notable increase in social anxiety since the start of the COVID-19 pandemic. This proposal will use iExposure to develop a personalized mechanism-focused approach to optimizing treatment response for individuals with social anxiety by testing standard iExposure against two augmentations that incorporate distinct attention mechanisms (attention guidance and attention control).
Eligibility
Inclusion Criteria: * Age 18 or older * Fluent in English * Leibowitz Social Anxiety Scale \> 47 and endorses both social anxiety items on the Web Screening Questionnaire for Common Mental Disorders Exclusion Criteria: * Currently receiving CBT for Social Anxiety Disorder * Significant visual impairment precluding engagement in the simulated teleconferencing interactions * Unstable dose of psychotropic medications within 6 weeks prior to baseline assessment * Current alcohol or substance use disorder * Current or past bipolar disorder or psychosis
Conditions2
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06409247